Hjem › Overvægt › Nevada › Las Vegas
Overvægt kliniske forsøg i Las Vegas, NV
27 studier for Overvægt søger deltagere på steder i og omkring Las Vegas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 2
- Vector Clinical Trials /ID# 282265, Las Vegas
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
- Excel Clinical Research, LLC, Las Vegas
- Palm Research Center Tenaya, Las Vegas
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RekruttererFase 3
- Palm Research Center Inc., Las Vegas
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Las Vegas
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RekruttererFase 3
- Palm Research Center Tenaya, Las Vegas
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekruttererFase 3
- Excel Clinical Research, Las Vegas
- Vector Clinical Trials, Las Vegas
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RekruttererFase 3
- AMR Clinical, Las Vegas
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RekruttererFase 2
- Las Vegas Medical Research, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RekruttererFase 3
- AURORA-1 Clinical Site, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RekruttererFase 3
- AURORA-2 Clinical Site, Las Vegas
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RekruttererFase 3Frivillige med god helbredstilstand velkomne
- ACCOMPLISH-2 Research Site, Las Vegas
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
RekruttererFase 3
- Jubilee Clinical Research, Inc., Las Vegas
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RekruttererFase 2
- Las Vegas Medical Research, Las Vegas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RekruttererFase 2
- Vector Clinical Trials, Las Vegas
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RekruttererFase 3
- Kailera Clinical Site, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RekruttererFase 3
- Palm Research Center Inc, Las Vegas
- Vector Clinical Trials, Las Vegas
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
RekruttererFase 3
- Kailera Clinical Site, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RekruttererFase 3
- Palm Research Center Inc, Las Vegas
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
RekruttererFase 3
- Kailera Clinical Site, Las Vegas
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RekruttererFase 3
- Excel Clinical Research, Las Vegas
Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
RekruttererFrivillige med god helbredstilstand velkomne
- University of Nevada, Las Vegas, Las Vegas
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
RekruttererFase 3
- Research Site, Las Vegas
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruttererFase 3
- UMC of Southern Nevada, Las Vegas
- Palm Research Center Inc-Vegas, Las Vegas
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RekruttererFase 3
- ACCOMPLISH-1 Research Site, Las Vegas
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
RekruttererFase 2
- Palm Research Center, Mountainview Medical Center, Las Vegas
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
RekruttererFase 3
- Jubilee Clinical Research, Inc., Las Vegas
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
RekruttererFase 1
- Corxel Investigational site, Las Vegas
Overvægt forsøg i andre byer
- Houston, TX43 studier
- Chicago, IL41 studier
- New York City, NY40 studier
- San Antonio, TX40 studier
- Washington, DC33 studier
- Orlando, FL31 studier
- Dallas, TX30 studier
- Boston, MA28 studier
- Miami, FL27 studier
- Baltimore, MD25 studier
- Jacksonville, FL25 studier
- St. Louis, MO25 studier
Andre studier i Las Vegas
- Overvægt23 studier
- Type 2-diabetes18 studier
- Ikke-småcellet lungecancer13 studier
- Alvorlig depressiv lidelse13 studier
- Brystkræft10 studier
- Alzheimers sygdom8 studier
- Prostatakræft8 studier
- Akut myeloid leukæmi8 studier
- Kræft (alle typer)8 studier
- Steatotisk leversygdom7 studier
- Livmoderslimhindekræft7 studier
- Depression7 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.